Patent Infringement Suit Against Indemnitee Forecloses IPR Petition by Indemnitor

May 29, 2024

Reading Time : 3 min

The Patent Trial and Appeal Board denied institution of a petition for inter partes review under 35 U.S.C. § 315(b) because the petition was filed more than one year after patent owner had served a complaint for patent infringement against a seller of accused lighting products. The PTAB concluded that the seller was a real party in interest (RPI) to petitioner based on an indemnification relationship between the two entities. Therefore, institution of the petition was time-barred because petitioner filed the petition more than a year after an RPI had been served with a complaint.

Petitioner and seller were parties to an agreement whereby petitioner agreed to indemnify seller against claims of patent infringement arising from seller’s use, sale, or offering for sale of goods provided by petitioner. In August 2022, patent owner filed a complaint alleging that seller’s importation, offering for sale, and selling the accused products infringed claims of six of patent owner’s patents. In October 2022, seller filed a third-party complaint against petitioner seeking indemnification. In its answer, petitioner filed crossclaims against patent owner seeking declaratory judgments of noninfringement and invalidity for each of the asserted patents. In October 2023, petitioner filed a petition for IPR against one of the asserted patents.

Patent owner argued, and the PTAB ultimately agreed, that seller was an RPI to petitioner because the IPR petition was filed at the behest of seller. In this regard, the board noted that seller made multiple demands for indemnification and petitioner acknowledged that it was liable for a portion of seller’s expenses and costs in the litigation. Petitioner also responded to seller’s demand for indemnification by seeking a declaration from the district court that the claims of the challenged patent were invalid. As further indication that petitioner’s and seller’s interests aligned, the PTAB observed that the invalidity grounds and prior art references set forth in the IPR petition largely overlapped with the invalidity contentions that seller and petitioner jointly served in the district court litigation. Further, the PTAB stated that seller stood to benefit from a favorable decision on the IPR petition as that would relieve seller from any liability for infringement.

The board rejected petitioner’s arguments that seller was not an RPI to the proceeding. Petitioner argued that its interests were not aligned with seller’s because petitioner was potentially liable to many more sellers of accused products, and a holding in favor of seller or a settlement between seller and patent owner would not necessarily apply to petitioner and its other customers. The PTAB stated that the objective of the RPI analysis was not to probe petitioner’s interest, but to assess the mutual interests of petitioner and seller. Petitioner also argued that it did not coordinate with seller in filing the IPR petition. The board noted that in the district court proceeding, petitioner and seller had communicated about indemnification through public court filings and coordinated on invalidity positions. The board distinguished this proceeding from cases in which an indemnification agreement alone, without something more, was insufficient to establish an RPI relationship.

Because seller was an RPI to the proceeding, petitioner’s IPR petition was time-barred under § 315(b) by patent owner’s filing of the infringement action against seller more than one year prior. In view of seller being an RPI, the board did not reach the question of whether seller was a “privy of the petitioner” under § 315(b).

Practice Tip: A determination of whether a party is an RPI requires both practical and equitable considerations with a focus on preexisting relationships with the petitioner to which the non-party benefits. A coordinated invalidity strategy between parties to an indemnification agreement and repeated demands by the non-party for indemnity may support a finding of RPI. Therefore, a party to an indemnification agreement wishing to file an IPR proceeding in view of an indemnity demand by a counterparty should carefully and promptly consider whether that party could be deemed to be an RPI. Delays in filing an IPR in this circumstance may risk the petition being time-barred under § 315(b).

Luminex Int’l Co. v. Signify Holdings B.V., IPR2024-00101, Paper 10 (P.T.A.B. May 9, 2024).

Share This Insight

Previous Entries

IP Newsflash

March 24, 2025

The Federal Circuit affirmed a Patent Trial and Appeal Board (PTAB) final written decision holding that the prior art exception of AIA Section 102(b)(2)(B) does not apply to a prior sale by an inventor when the sale is conducted in private. According to the Federal Circuit, a sale must disclose the relevant aspects of the invention to the public to qualify for the prior art exception of Section 102(b)(2)(B).

...

Read More

IP Newsflash

March 21, 2025

Under the Lanham Act, a plaintiff who prevails on a trademark infringement claim may be entitled to recover the “defendant’s profits” as damages. The Supreme Court in Dewberry Group, Inc. v. Dewberry Engineers Inc. unanimously construed “defendant’s profits” in 35 USC § 1117(a) to mean that only the named defendant’s profits can be awarded, not the profits of other related corporate entities. The Court, however, left open the possibility that other language in § 1117(a) may allow for damages linked to the profits of related entities, if properly raised and supported.

...

Read More

IP Newsflash

March 13, 2025

In a series of rulings on a motion in limine, the District of Delaware recently distinguished between what qualifies as being incorporated by reference and what does not for the purposes of an anticipation defense. In short, a parenthetical citation was held to be insufficient, while three passages discussing a cited reference met the test.

...

Read More

IP Newsflash

March 4, 2025

On February 28, 2025, the USPTO announced that it was rescinding former Director Vidal’s 2022 memorandum on discretionary denials by the Patent Trial and Appeal Board. The 2022 memorandum effectively narrowed the application of discretionary denials in cases with parallel district court litigation by specifying instances where discretionary denial could not be issued. With the withdrawal of the memorandum, individual PTAB panels will regain flexibility in weighing discretionary denials. While the long-term effect of that increased flexibility is not yet known, the immediate effect is likely to be a shift towards the discretionary analysis applied by PTAB panels before the issuance of the memorandum.

...

Read More

IP Newsflash

March 3, 2025

A District of Delaware judge recently granted a defendant’s motion to include a patent prosecution bar in its proposed protective order after determining that litigation counsel’s ability to practice before the Patent Office—without ever having represented the plaintiffs at the Patent Office in the past—weighed heavily in favor of the bar.

...

Read More

IP Newsflash

February 12, 2025

The Federal Circuit recently reversed a district court decision that found a patent that did not describe after-arising technology failed to satisfy the written description requirement. In so doing, the Federal Circuit explained that written description and enablement are evaluated based on the subject matter that is claimed, not the products that practice those claims. As a result, the patentee was not required to describe unclaimed, later-discovered features of the accused products despite the broad language in the claims that undisputedly covered the products.

...

Read More

IP Newsflash

January 24, 2025

The District of Delaware recently rejected a patentee’s argument that non-production of an opinion letter from counsel, combined with knowledge of the patent, warranted a finding that defendant induced infringement.

...

Read More

IP Newsflash

January 17, 2025

The District of Delaware recently denied a motion to dismiss a patent infringement complaint involving gene editing technology that sought relief under the Safe Harbor Provision of the Hatch-Waxman Act. Specifically, the court found the patentee’s complaint sufficiently alleged at least some uses of the claimed technology that, when taken as true, were not solely uses of a “patented invention” that were “reasonably related” to an FDA submission.

...

Read More

© 2025 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.